Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current Pandemic scenario, all articles related to Coronavirus will be processed on a quick track basis, to ensure timely review and publication of much needed research

Contents

Current Pharmaceutical Design, Volume 14 - Number 31



Receptor Binding Ligands to Image Infection

, 14(31): 3316 - 3325

M. Chianelli, O. C. Boerman, G. Malviya, F. Galli, W. J.G. Oyen and A. Signore


DOI: 10.2174/138161208786549416



Growth Factor/Peptide Receptor Imaging for the Development of Targeted Therapy in Oncology

, 14(31): 3340 - 3347

Christophe Van de Wiele, Hendricus Boersma, Rudi A. Dierckx, Bart De Spiegeleer, Aren Van Waarde and Philip H. Elsinga


DOI: 10.2174/138161208786549434


Immunoscintigraphy as Potential Tool in the Clinical Evaluation of HER2/neu Targeted Therapy

, 14(31): 3348 - 3362

Eli C.F. Dijkers, Elisabeth G.E. de Vries, Jos G.W. Kosterink, Adrienne H. Brouwers and Marjolijn N. Lub-de Hooge


DOI: 10.2174/138161208786549425




Editor-in-Chief

William A. Banks
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
(USA)

Biography View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32

Advertisement

Covid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog